quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:56:30·45d
SECFiling
Coherus Oncology Inc. logo

SEC Form 10-K filed by Coherus Oncology Inc.

CHRS· Coherus Oncology Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • CHRS
    Coherus Oncology Inc.
    Health Care

Recent analyst ratings

  • Jan 23UpdateOppenheimer$10.00
  • Sep 4UpdateMaxim Group-
  • Aug 16UpdateUBS$1.50
  • Nov 17UpdateRobert W. Baird$11.00
  • Nov 8UpdateMaxim Group-
  • Jul 24UpdateCitigroup$12.00

Related

  • SEC4d
    SEC Form DEF 14A filed by Coherus Oncology Inc.
  • SEC9d
    SEC Form DEFA14A filed by Coherus Oncology Inc.
  • SEC14d
    SEC Form PRE 14A filed by Coherus Oncology Inc.
  • SEC28d
    Amendment: SEC Form SCHEDULE 13G/A filed by Coherus Oncology Inc.
  • SEC45d
    Coherus Oncology Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • PR45d
    Coherus Oncology Reports Full Year and Fourth Quarter 2025 Financial Results and Provides Business Update
  • PR52d
    Coherus Oncology to Report Full Year and Fourth Quarter 2025 Financial Results on March 9, 2026
  • PR59d
    Coherus Oncology to Participate in Upcoming Investor Conferences
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022